Long Island Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
1,037
+1
+0.1% +$1.02K 0.51% 39
2026
Q1
$953K Buy
1,036
+6
+0.6% +$6.08K 0.44% 42
2025
Q4
$1.11M Hold
1,030
0.52% 41
2025
Q3
$786K Buy
1,030
+10
+1% +$7.44K 0.38% 49
2025
Q2
$795K Sell
1,020
-5
-0.5% -$3.88K 0.41% 46
2025
Q1
$847K Hold
1,025
0.52% 43
2024
Q4
$791K Hold
1,025
0.5% 46
2024
Q3
$908K Hold
1,025
0.6% 41
2024
Q2
$928K Hold
1,025
0.65% 38
2024
Q1
$797K Buy
1,025
+5
+0.5% +$3.56K 0.56% 41
2023
Q4
$595K Buy
+1,020
New +$595K 0.42% 46

Other funds holding LLY

Long Island Wealth Management's LLY Position: Q2 2026 in Review

Long Island Wealth Management increased its Eli Lilly (LLY) stake by 0.1% in Q2 2026, buying an estimated $1.02K and bringing the position to 1,037 shares worth $1.24M. The position accounts for 0.51% of the portfolio, ranked #39.

Long Island Wealth Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Long Island Wealth Management held 1,037 shares of Eli Lilly worth $1.24M as of Q2 2026.
  • Long Island Wealth Management bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.51% of Long Island Wealth Management's portfolio in Q2 2026, its #39 holding.
  • Long Island Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Long Island Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.